2022 annual financial data
Stoke Therapeutics 2022 Net margin
Direct answer
Net margin was -750.58%.
Operating income was -104,356,000 USD and net income was -93,110,000 USD.
Operating cash flow was -31,866,000 USD.
Get free Stoke Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,405,000 USD
- Operating income
- -104,356,000 USD
- Net income
- -93,110,000 USD
- Operating cash flow
- -31,866,000 USD